Dale Hsieh
Psychiatry · Austin, TXNPI 1871796607
Payments from drug & device makers
Across 219 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$834
- Supernus Pharmaceuticals, Inc.$591
- Vanda Pharmaceuticals Inc.$530
- Eisai Inc.$504
- Takeda Pharmaceuticals U.S.A., Inc.$395
- plus $807 from 7 others
What the payments were for
- Food & beverage$4,73399%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $1,137 |
| Otsuka America Pharmaceutical, Inc. | 33 | $834 |
| Supernus Pharmaceuticals, Inc. | 28 | $591 |
| Vanda Pharmaceuticals Inc. | 16 | $530 |
| Eisai Inc. | 26 | $504 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $395 |
| Corium, LLC | 9 | $289 |
| Lundbeck LLC | 14 | $252 |
| Alkermes, Inc. | 11 | $183 |
| Neurocrine Biosciences, Inc. | 1 | $36 |
| Johnson & Johnson | 1 | $17 |
| Neos Therapeutics, LP | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,798 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 47 | $1,154 |
| Carbamazepine | 24 | $447 |
| Escitalopram Oxalate | 71 | $447 |
| Fluvoxamine Maleate | 13 | $376 |
| Bupropion XlBupropion Hcl | 26 | $237 |
| Alprazolam | 26 | $217 |
| Quetiapine Fumarate | 34 | $212 |
| Lamotrigine | 31 | $183 |
| Bupropion Hcl | 11 | $158 |
| Trazodone Hcl | 19 | $109 |
| Haloperidol | 16 | $103 |
| Gabapentin | 35 | $96 |
| Fluoxetine Hcl | 16 | $82 |
| Lithium Carbonate ErLithium Carbonate | 11 | $78 |
| Lorazepam | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Austin
- David BrownAustin$15.8M
- Divyansu PatelAustin$2.8M
- Donald GarciaAustin$2.8M
- Arvinder Pal WaliaAustin$2.5M
- Charles SweetAustin$520K
- Charles NemeroffAustin$429K
- Scott BartleyDallas$42.7M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.